Editorial Commentary
Radiomics of soft tissue sarcoma metastases to assess prognostic factors related to intrapatient intertumor heterogeneity
Translational Cancer Research
2026;
15
(1)
:1
.
(31 January 2026)
Leveraging cell’s endogenous regulatory network: towards safer and more effective CAR T cell therapies for solid tumors
Translational Cancer Research
2026;
15
(1)
:2
.
(31 January 2026)
The use of stereotactic ablative body radiotherapy (SABR) for oligoprogressive cancers
Translational Cancer Research
2026;
15
(1)
:3
.
(31 January 2026)
Precision targeting of CCNE1-amplified tumors—lessons from BLU-222 and beyond
Translational Cancer Research
2026;
15
(1)
:4
.
(31 January 2026)
Tertiary lymphoid structures: prognostic insights and implications for immunotherapy in HPV-negative head and neck cancer
Translational Cancer Research
2026;
15
(1)
:5
.
(31 January 2026)
Original Article
A Cori cycle-related gene signature predicts prognosis, immune microenvironment, and drug response in breast cancer
Translational Cancer Research
2026;
15
(1)
:6
.
(31 January 2026)
Development and validation of a clinical-radiomics nomogram for the differential diagnosis of focal pancreatic solid lesions: a retrospective cohort study
Translational Cancer Research
2026;
15
(1)
:7
.
(31 January 2026)
IL20RB as a prognostic and immune-related biomarker in lung cancer: association with immune infiltration, tumor progression, and potential therapeutic targeting
Translational Cancer Research
2026;
15
(1)
:8
.
(31 January 2026)
METTL16 antagonizes astaxanthin-induced ferroptosis in colorectal cancer cells
Translational Cancer Research
2026;
15
(1)
:9
.
(31 January 2026)
F-box protein 28 serves as a prognostic and predictive biomarker for gastric cancer
Translational Cancer Research
2026;
15
(1)
:10
.
(31 January 2026)
Total flavonoids extracted from Penthorum chinense Pursh inhibits oxidative stress and inflammation in liver cancer cells through the JAK2/STAT3 pathway
Translational Cancer Research
2026;
15
(1)
:11
.
(31 January 2026)
Effect of folic acid-targeted triptolide-loaded microbubbles combined with ultrasound on apoptosis of human MCF-7 breast cancer xenografts in nude mice
Translational Cancer Research
2026;
15
(1)
:12
.
(31 January 2026)
Hsa_circ_0001756, a novel biomarker, promotes breast cancer progression via miR-584-5p/TRAF6 signaling axis
Translational Cancer Research
2026;
15
(1)
:13
.
(31 January 2026)
Therapeutic efficacy evaluation of the injection mucosa knife in endoscopic submucosal dissection for rectal neuroendocrine tumors
Translational Cancer Research
2026;
15
(1)
:14
.
(31 January 2026)
CREM regulates the tumor immune microenvironment and predicts prognosis in thyroid carcinoma
Translational Cancer Research
2026;
15
(1)
:15
.
(31 January 2026)
Prognostic nomograms for overall and cancer-specific survival in individuals with large cell neuroendocrine carcinoma: a population-based study
Translational Cancer Research
2026;
15
(1)
:16
.
(31 January 2026)
Efficacy and safety of neoadjuvant chemotherapy combined with concurrent chemoradiotherapy and concurrent chemoradiotherapy alone in locally advanced cervical cancer: a systematic review and meta-analysis
Translational Cancer Research
2026;
15
(1)
:17
.
(31 January 2026)
The WT 1-AS/miR-206 axis regulates the proliferation and migration of breast cancer through the cuproptosis related gene BCL11A
Translational Cancer Research
2026;
15
(1)
:18
.
(31 January 2026)
CD36 as a potential prognostic biomarker and modulator of the tumor microenvironment in glioma
Translational Cancer Research
2026;
15
(1)
:19
.
(31 January 2026)
Toward individualized prognosis in primary breast diffuse large B-cell lymphoma: incidence trends and a predictive model
Translational Cancer Research
2026;
15
(1)
:20
.
(31 January 2026)
Multi-omics analysis links FERMT1 expression to patient survival, immunotherapy response, and metastasis across cancers
Translational Cancer Research
2026;
15
(1)
:21
.
(31 January 2026)
Preoperative peripheral blood lymphocyte subsets integrated with geriatric nutritional risk index for prognostic assessment in elderly colorectal carcinoma patients
Translational Cancer Research
2026;
15
(1)
:22
.
(31 January 2026)
PHGDH knockdown activates autophagic flux to suppress migration and invasion of gastric cancer cells
Translational Cancer Research
2026;
15
(1)
:23
.
(31 January 2026)
GNAL-driven calcium signaling reshapes the spatiotemporal immune landscape in ER+ breast cancer: causal insights and prognostic implications
Translational Cancer Research
2026;
15
(1)
:24
.
(31 January 2026)
Establishment of a model to predict the recurrence time of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer
Translational Cancer Research
2026;
15
(1)
:25
.
(31 January 2026)
Single-cell analysis reveals the prognostic role of immune escape in the colorectal cancer microenvironment
Translational Cancer Research
2026;
15
(1)
:26
.
(31 January 2026)
Prognostic value of palmitoylation-regulated mechanisms in glioblastoma: integrated multi-omics analysis via least absolute shrinkage and selection operator (LASSO) regression and single-cell sequencing
Translational Cancer Research
2026;
15
(1)
:27
.
(31 January 2026)
Establishment and validation of a prognostic model based on liquid-liquid phase separation-related genes in gastric cancer
Translational Cancer Research
2026;
15
(1)
:28
.
(31 January 2026)
Novel fatty acid metabolism-related molecular subtyping and prognostic signature for breast cancer
Translational Cancer Research
2026;
15
(1)
:29
.
(31 January 2026)
Macrophage-associated SLAMF9 is a potential therapeutic target for glioma
Translational Cancer Research
2026;
15
(1)
:30
.
(31 January 2026)
Development and verification of a competing risk model for forecasting cancer-specific survival in malignant bone tumor patients: an analysis of SEER database
Translational Cancer Research
2026;
15
(1)
:31
.
(31 January 2026)
Temporal-spatial evolution of tumor habitat analysis: a bibliometric study on research hotspots and trends in medical imaging (2014–2025)
Translational Cancer Research
2026;
15
(1)
:32
.
(31 January 2026)
SanHuang decoction may suppress breast cancer by regulating M1 macrophage polarization via NF-κB signaling pathway: in vitro and in vivo studies
Translational Cancer Research
2026;
15
(1)
:33
.
(31 January 2026)
Risk factors and nomogram for early mortality in young patients with non-metastatic gastric cancer
Translational Cancer Research
2026;
15
(1)
:34
.
(31 January 2026)
Key genes and pathway differences between serrated polyps and conventional adenomas: insights from multi-omics
Translational Cancer Research
2026;
15
(1)
:35
.
(31 January 2026)
Sodium selenite promotes apoptosis and augments autophagic flux in cervical cancer cells by activating the YAP-Hippo signaling pathway
Translational Cancer Research
2026;
15
(1)
:36
.
(31 January 2026)
Evaluating differentiation grade as a guide for decision-making in elective neck dissection for early-stage oral squamous cell carcinoma: a population-based cohort study
Translational Cancer Research
2026;
15
(1)
:37
.
(31 January 2026)
VDAC1 and VDAC2 as prognostic biomarkers and therapeutic targets in hepatocellular carcinoma
Translational Cancer Research
2026;
15
(1)
:38
.
(31 January 2026)
Secretogranin II serves as a potential prognostic biomarker and correlates with the immune microenvironment in pancreatic neuroendocrine tumors
Translational Cancer Research
2026;
15
(1)
:39
.
(31 January 2026)
Integrative machine learning of hypoxia and centrosome-related gene signatures enables prognostic stratification and therapeutic insights in lung adenocarcinoma
Translational Cancer Research
2026;
15
(1)
:40
.
(31 January 2026)
Integrated single-cell and transcriptomic analysis of CD8+CD101+TIM3+ T cells in hepatocellular carcinoma: implications for tumor microenvironment and prognostic modeling
Translational Cancer Research
2026;
15
(1)
:41
.
(31 January 2026)
Orphan G protein-coupled receptor GPR137 regulates ferroptosis by targeting the Wnt/β-catenin pathway in sonic hedgehog-medulloblastoma
Translational Cancer Research
2026;
15
(1)
:42
.
(31 January 2026)
Clinical utility of OGN in pan-cancer: diagnostic biomarker and immune microenvironment regulator
Translational Cancer Research
2026;
15
(1)
:43
.
(31 January 2026)
Multiplex droplet digital polymerase chain reaction for rapid diagnosing suspected bloodstream infections in patients with hematologic malignancies
Translational Cancer Research
2026;
15
(1)
:44
.
(31 January 2026)
Association of METTL14 expression with prognosis and immunotherapy in breast cancer
Translational Cancer Research
2026;
15
(1)
:45
.
(31 January 2026)
Single-patient single-cell RNA sequencing reveals neuroendocrine predominance and immunosuppression in small-cell lung cancer
Translational Cancer Research
2026;
15
(1)
:46
.
(31 January 2026)
The atypical kinase right open reading frame kinase 1 suppresses glioma cell growth through mammalian target of rapamycin inhibition and apoptotic signaling activation
Translational Cancer Research
2026;
15
(1)
:47
.
(31 January 2026)
Development and validation of a herb-related gene signature for prognosis prediction and therapeutic response assessment in breast cancer
Translational Cancer Research
2026;
15
(1)
:48
.
(31 January 2026)
A novel prognostic model for colon adenocarcinoma based on cofactor and vitamin metabolism-related genes
Translational Cancer Research
2026;
15
(1)
:49
.
(31 January 2026)
SUMOylation of UBE2C facilitates hepatocellular carcinoma proliferation and invasion via the MAPK pathway
Translational Cancer Research
2026;
15
(1)
:50
.
(31 January 2026)
Role of TRAIL in mediating the effect of lipidome on breast cancer: a Mendelian randomization study
Translational Cancer Research
2026;
15
(1)
:51
.
(31 January 2026)
Integrating WGCNA and machine learning algorithm to identify ACSM5 as a prognostic biomarker and therapeutic target for predicting immunotherapy efficacy in non-small cell lung cancer
Translational Cancer Research
2026;
15
(1)
:52
.
(31 January 2026)
Development and validation of a machine learning model for predicting early death in metastatic pancreatic ductal adenocarcinoma: a study based on the SEER database
Translational Cancer Research
2026;
15
(1)
:53
.
(31 January 2026)
Identification of necrosis-related signature for predicting prognosis and immunotherapy response in gastric cancer
Translational Cancer Research
2026;
15
(1)
:54
.
(31 January 2026)
Evaluation of parietal pleural invasion in subpleural lung cancer by VEGFR2 targeted microbubble-based ultrasound molecular imaging
Translational Cancer Research
2026;
15
(1)
:55
.
(31 January 2026)
A nomogram to predict disease-free survival in patients with residual triple-negative breast cancer after neoadjuvant chemotherapy based on clinicopathological and sonographic features
Translational Cancer Research
2026;
15
(1)
:56
.
(31 January 2026)
Prognostic characteristics, recurrence patterns and survival outcomes of uterine papillary serous carcinoma: a single-centre retrospective cohort study
Translational Cancer Research
2026;
15
(1)
:57
.
(31 January 2026)
MicroRNA-374b-5p suppresses osteosarcoma progression via the PDPK1-mediated AKT pathway
Translational Cancer Research
2026;
15
(1)
:58
.
(31 January 2026)
ARHGAP11A affects lung adenocarcinoma (LUAD) and pancreatic adenocarcinoma (PAAD) progression by regulating FAM83A
Translational Cancer Research
2026;
15
(1)
:59
.
(31 January 2026)
A circulating microRNA-based diagnostic model for breast cancer, in which the miR-139-3p/RPA2 axis regulates the sensitivity to DNA-damaging agents
Translational Cancer Research
2026;
15
(1)
:60
.
(31 January 2026)
EGCG promotes apoptosis in BT-549 triple-negative breast cancer cells by targeting STAT3
Translational Cancer Research
2026;
15
(1)
:61
.
(31 January 2026)
Inhibition of radiotherapy sensitivity in nasopharyngeal carcinoma via the long non-coding RNA RHPN1-AS1
Translational Cancer Research
2026;
15
(1)
:62
.
(31 January 2026)
Brief Report
Survival and response outcomes in patients with recurrent/metastatic head and neck cancer treated with opioids and statins: an exploratory pilot study
Translational Cancer Research
2026;
15
(1)
:63
.
(31 January 2026)
Review Article
Modern radiotherapy in inoperable locally advanced non-small cell lung cancer: a review of techniques, dose fractionation, and immuno-synergistic strategies
Translational Cancer Research
2026;
15
(1)
:64
.
(31 January 2026)
Tumor microenvironment-guided targeted and immunotherapy in anaplastic thyroid cancer: a literature review from preclinical models to clinical translation
Translational Cancer Research
2026;
15
(1)
:65
.
(31 January 2026)
Introduction to animal modelling: factors and tools for choosing the optimal model for sarcoma research—a comprehensive literature review
Translational Cancer Research
2026;
15
(1)
:66
.
(31 January 2026)
Therapeutic application of IL-12 for cancer therapy
Translational Cancer Research
2026;
15
(1)
:67
.
(31 January 2026)
Optimizing the therapeutic ratio: a narrative review of de-escalation and response-adapted strategies in series including human papillomavirus negative head and neck cancer
Translational Cancer Research
2026;
15
(1)
:68
.
(31 January 2026)
Case Report: iMDT Corner
A case report of hemophagocytic lymphohistiocytosis secondary to tislelizumab and bevacizumab combination therapy for renal cell carcinoma
Translational Cancer Research
2026;
15
(1)
:69
.
(31 January 2026)
Case Report
Prolonged survival with alectinib in a patient with advanced lung adenocarcinoma: a case report and literature review
Translational Cancer Research
2026;
15
(1)
:70
.
(31 January 2026)
